Loading candles…
Mukka Proteins Ltd, incorporated in 2003, is a key player in the Indian marine protein industry. The company manufactures and exports fishmeal, fish oil, and fish-soluble paste and has expanded its operations to include insect-based alternate proteins and frozen seafood products. Serving the aquaculture, poultry, and livestock sectors globally, Mukka Proteins holds an estimated 25% to 30% market share in India's fishmeal and fish oil segment. Its business segments encompass fishmeal manufacturing and export, fish oil manufacturing and export, fish-soluble paste manufacturing and export, insect-based alternate proteins, and the frozen seafood sector. The company's product portfolio includes fishmeal, fish oil, fish-soluble paste, insect-based protein products, and frozen seafood. Mukka Proteins operates primarily in India while catering to global markets, supporting aquaculture, poultry, and livestock industries worldwide.
This page is a live market overview for MUKKA PROTEINS LIMITED (MUKKA) on the NSE. As a listed security, MUKKA PROTEINS LIMITED is tracked in the Fast Moving Consumer Goods segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for MUKKA before placing trades on tick2trade.
As of the latest feed, MUKKA last traded at ₹27.18 on NSE, down ₹0.19 (0.69%) from the previous close of ₹27.37. Today's session range is ₹26.51 – ₹28.15, against a 52-week band of ₹18.27 – ₹33.29. Traded volume today stands at 3.85L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for MUKKA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether MUKKA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for MUKKA PROTEINS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in MUKKA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated MUKKA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | To consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and three months period ended 30th June … | 12 Aug 2026 |
| Fund Raising | To consider Fund Raising and other business matters | 12 Jun 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters | 15 May 2026 |
| Results - FY25 | MUKKA : 12-Feb-2026 : The Company has informed the Exchange that a Board meeting to be held on February 10, 2026 has been re-scheduled. Further, the Company… | 12 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 10 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 12 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 13 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 15 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.